DEA Schedule CIV
Strength
5; 2.5 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332074431
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216969On Market Since
10/4/2023
Pharmacological Classes
Anticholinergic
Benzodiazepine
Benzodiazepines
Cholinergic Antagonists
Decreased Parasympathetic Acetylcholine Activity
Digestive/GI System Activity Alteration
GI Motility Alteration
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
CLONAZEPAM 0.5 MG TABLET
Generic
00093083201•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00093083205•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00904722761•Major Pharmaceuticals
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013600•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013616•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040610•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040611•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040650•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
50268017315•AvPAK
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
59651072201•Aurobindo Pharma Limited
$0.0200
per EA